Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
Leave your feedback
A shortage of baby formula in the U.S. should be over and supplies will be “beyond normal” within two months, the head of the Food and Drug Administration said on Thursday.
Watch the event in the player above.
“I can’t be exact about this, but my expectation is that within two months we should be beyond normal and with a plethora [of options],” FDA Commissioner Dr. Robert Califf told the Senate Committee on Health.
Califf said that because of actions by the government, the supply of baby formula would get “better and better” before then.
He said that specialty formulas were being prioritized and would be the first products when baby formula maker Abbott resumes production at its shuttered Sturgis facility.
“They’ve been able to move their timeline up now to within a month [when] they will have that specialty formula out,” Califf said.
The baby formula shortage stems mostly from Abbott Nutrition’s plant in Sturgis, Michigan, which the FDA closed in February due to contamination issues. Abbott, one of a handful of companies that control the vast majority of the market for infant formula, then announced a massive recall of its product on Feb. 17, which led to the nationwide supply shortage.
Abbott and the FDA recently reached an agreement to reopen the plant next week. But it will take about two months before product is ready for delivery.
Support Provided By:
Additional Support Provided By: